{"id":4619,"date":"2024-12-24T09:49:38","date_gmt":"2024-12-24T08:49:38","guid":{"rendered":"https:\/\/delinaprej.eu\/?p=4619"},"modified":"2024-12-24T09:50:18","modified_gmt":"2024-12-24T08:50:18","slug":"rusija-lansira-brezplacno-cepivo-proti-raku-brezplacna-distribucija-se-bo-zacela-leta-2025","status":"publish","type":"post","link":"https:\/\/delinaprej.eu\/index.php\/2024\/12\/24\/rusija-lansira-brezplacno-cepivo-proti-raku-brezplacna-distribucija-se-bo-zacela-leta-2025\/","title":{"rendered":"Rusija lansira brezpla\u010dno cepivo proti raku: brezpla\u010dna distribucija se bo za\u010dela leta 2025 \ud83c\uddf8\ud83c\uddee"},"content":{"rendered":"<p><em>Avtor: Saumya Joshi \u010cas objave: sreda, 18. december 2024, 20:53<\/em><\/p>\n<p>Rusija je objavila prelomno sporo\u010dilo o razvoju cepiva mRNA proti raku, ki je namenjeno zdravljenju bolnikov. Cepivo bo na voljo od za\u010detka leta 2025 in bo ruskim dr\u017eavljanom razdeljeno brezpla\u010dno. Vsak odmerek naj bi dr\u017eavo stal 300.000 rubljev (pribli\u017eno 2.869 USD).<br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-4620 size-full\" src=\"https:\/\/delinaprej.eu\/wp-content\/uploads\/2024\/12\/vaccine-s-1734533337.webp\" alt=\"\" width=\"600\" height=\"338\" srcset=\"https:\/\/delinaprej.eu\/wp-content\/uploads\/2024\/12\/vaccine-s-1734533337.webp 600w, https:\/\/delinaprej.eu\/wp-content\/uploads\/2024\/12\/vaccine-s-1734533337-300x169.webp 300w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/p>\n<p>&nbsp;<\/p>\n<h5>Zakaj je cepivo pomembno<\/h5>\n<p>Ker \u0161tevilo primerov raka nara\u0161\u010da, naj bi to novo cepivo v Rusiji korenito spremenilo zdravljenje raka. Deluje tako, da pomaga bolnikovemu imunskemu sistemu prepoznati in se boriti proti dolo\u010denim rakavim celicam. V nasprotju s tradicionalnimi cepivi, ki prepre\u010dujejo bolezni, to cepivo zdravi obstoje\u010de rake tako, da uporablja dele bolnikovega tumorja za usposabljanje imunskega sistema.<\/p>\n<p>&nbsp;<\/p>\n<h5>Personalizacija z napredno tehnologijo<\/h5>\n<p>Cepivo je prilagojeno vsakemu bolniku. Znanstveniki z naprednimi tehnikami umetne inteligence obdelajo podatke in ustvarijo edinstveno cepivo za individualne potrebe. Po besedah Aleksandra Gintsburga, direktorja nacionalnega raziskovalnega centra Gamaleya, postopek vklju\u010duje uporabo nevronskih mre\u017e, ki ta cepiva ustvarijo v 30 minutah do eni uri.<\/p>\n<p>&nbsp;<\/p>\n<h5>Nara\u0161\u010dajo\u010de \u0161tevilo primerov raka v Rusiji leta 2022<\/h5>\n<p>Rusija zabele\u017eila ve\u010d kot 635.000 primerov raka, med katerimi so najpogostej\u0161i rak debelega \u010drevesa, dojk in plju\u010d. To cepivo daje upanje tistim, ki se borijo s temi boleznimi, in poudarja zavezanost dr\u017eave k izbolj\u0161anju oskrbe raka.<\/p>\n<p>&nbsp;<\/p>\n<h5>Globalni napredek na podro\u010dju cepiv proti raku<\/h5>\n<p>Prizadevanja Rusije se pridru\u017eujejo svetovni tekmi za ustvarjanje prilagojenih cepiv proti raku. V ZDA so raziskovalci na Univerzi na Floridi testirali podobno cepivo na bolnikih z glioblastomom in pokazali obetavne rezultate pri spro\u017eitvi imunskega sistema v 48 urah. V Zdru\u017eenem kraljestvu medtem preizku\u0161ajo prilagojeno cepivo za melanom, ki je pokazalo bolj\u0161e pre\u017eivetje bolnikov.<\/p>\n<p>&nbsp;<\/p>\n<h5>Pot naprej<\/h5>\n<p>\u010ceprav nadaljnje podrobnosti o u\u010dinkovitosti cepiva in posebnih vrstah raka, na katere je cepivo usmerjeno, ostajajo nejasne, njegova uvedba pomeni pomemben korak naprej pri zdravljenju raka. Rusija \u017eeli z brezpla\u010dnim cepivom zmanj\u0161ati breme raka in voditi napredek na podro\u010dju personalizirane medicine.<\/p>\n<p>&nbsp;<\/p>\n<p>Svet bo s pribli\u017eevanjem leta 2025 pozorno spremljal, kako se bo ta pobuda razvijala, saj bo milijonom ljudi v Rusiji dala upanje in morda postavila temelje za podobne dose\u017eke po vsem svetu.<\/p>\n<p><em>Vir: <a href=\"https:\/\/www.oneindia.com\/international\/russia-launches-free-cancer-vaccine-free-distribution-to-begin-in-2025-4019757.html?ref=DMDesc\" target=\"_blank\" rel=\"noopener\">https:\/\/www.oneindia.com\/international\/russia-launches-free-cancer-vaccine-free-distribution-to-begin-in-2025-4019757.html?ref=DMDesc<\/a><\/em><\/p>\n<p>*** Prevod <a href=\"https:\/\/www.deepl.com\/Translator\" target=\"_blank\" rel=\"noopener\">www.DeepL.com\/Translator<\/a> (free version) ***<\/p>\n<p><a href=\"https:\/\/delinaprej.eu\/wp-content\/uploads\/2023\/08\/NoAI_sl_en.png\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-3249 size-medium aligncenter\" src=\"https:\/\/delinaprej.eu\/wp-content\/uploads\/2023\/08\/NoAI_sl_en-300x267.png\" alt=\"\" width=\"300\" height=\"267\" srcset=\"https:\/\/delinaprej.eu\/wp-content\/uploads\/2023\/08\/NoAI_sl_en-300x267.png 300w, https:\/\/delinaprej.eu\/wp-content\/uploads\/2023\/08\/NoAI_sl_en-768x683.png 768w, https:\/\/delinaprej.eu\/wp-content\/uploads\/2023\/08\/NoAI_sl_en.png 900w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rusija je objavila prelomno sporo\u010dilo o razvoju cepiva mRNA proti raku, ki je namenjeno zdravljenju bolnikov. Cepivo bo na voljo od za\u010detka leta 2025 in bo ruskim dr\u017eavljanom razdeljeno brezpla\u010dno. Vsak odmerek naj bi dr\u017eavo stal 300.000 rubljev (pribli\u017eno 2.869 USD).<\/p>\n","protected":false},"author":1,"featured_media":4620,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[41,5],"tags":[],"class_list":["post-4619","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cepiva-vakcine","category-medicina"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/posts\/4619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/comments?post=4619"}],"version-history":[{"count":9,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/posts\/4619\/revisions"}],"predecessor-version":[{"id":4632,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/posts\/4619\/revisions\/4632"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/media\/4620"}],"wp:attachment":[{"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/media?parent=4619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/categories?post=4619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/tags?post=4619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}